Why the GSK share price is a FTSE 100 dividend growth opportunity I’d buy today

Peter Stephens | Thursday, 13th December, 2018

GlaxoSmithKline plc (LON: GSK) could offer better income investing potential than the FTSE 100 (INDEXFTSE: UKX). More »

Are the BT and GlaxoSmithKline share prices the best FTSE 100 dividend choices?

Royston Wild | Tuesday, 11th December, 2018

Royston Wild considers whether BT Group plc (LON: BT-A) or GlaxoSmithKline plc (LON: GSK) is the superior FTSE 100 (INDEXFTSE: UKX) dividend share. More »

Should you buy the GSK share price after last week’s 10% fall?

Roland Head | Sunday, 9th December, 2018

Roland Head updates his rating on GlaxoSmithKline plc (LON:GSK) following news of two big deals. More »

Thinking of buying the GlaxoSmithKline share price? Read this first

Rupert Hargreaves | Friday, 7th December, 2018

GlaxoSmithKline plc (LON: GSK) might look cheap, but there's a reason why the market is dumping the company says Rupert Hargreaves. More »

Why I’d snap up the GSK share price for Christmas

Alan Oscroft | Friday, 30th November, 2018

I think the GlaxoSmithKline plc (LON: GSK) share price is lagging behind the turnaround in the company's fortunes. More »

3 top dividend stocks I’d buy right now

Andy Ross | Sunday, 25th November, 2018

Could these big dividend-paying stocks help investors grow their wealth even during the final Brexit negotiations? More »

Forget the best easy-access savings rate. I’d pick up a 5.1% yield with GSK shares

Edward Sheldon, CFA | Saturday, 17th November, 2018

You could earn 1.5% from a savings account, or you could pick up 5.1% from GlaxoSmithKline plc (LON: GSK) shares, explains Edward Sheldon. More »

3 FTSE 100 shares I’d buy right now in this fallen market

Kevin Godbold | Friday, 16th November, 2018

Why these FTSE 100 (INDEXFTSE:UKX) firms sit firmly on my ‘buy’ list. More »

Is GlaxoSmithKline a screaming buy after this news?

Rupert Hargreaves | Saturday, 10th November, 2018

Following the results of a landmark drug trial, GlaxoSmithKline plc (LON: GSK) could be a screaming buy, says Rupert Hargreaves. More »

The GSK share price has soared 15%. Here’s why I think the FTSE 100 stock can’t be ignored

Peter Stephens | Friday, 9th November, 2018

GlaxoSmithKline plc (LON: GSK) could offer stronger prospects than the FTSE 100 (INDEXFTSE: UKX). More »

To the lifeboats! 3 FTSE 100 stocks I think are perfect for volatile times like these

Royston Wild | Sunday, 4th November, 2018

Royston Wild picks out three terrific FTSE 100 (INDEXFTSE: UKX) shares to load up on today. More »

After its earnings call, should you buy into the GSK share price?

Tezcan Gecgil, PhD | Thursday, 1st November, 2018

Does GlaxoSmithKline plc (LON: GSK) represent a buying opportunity right now? More »

Top shares for November

The Motley Fool Staff | Thursday, 1st November, 2018

We asked our writers to share their top stock picks for the month. More »

Why I think it might finally be time to buy FTSE 100 dividend stock GlaxoSmithKline

Paul Summers | Wednesday, 31st October, 2018

Shares in drugmaker GlaxoSmithKline plc (LON:GSK) responded well to an update on trading. Paul Summers likes the stock a lot more than he used... More »

Is the GSK share price heading for 2,000p again?

Alan Oscroft | Tuesday, 30th October, 2018

After years of going nowhere, can GlaxoSmithKline plc (LON: GSK) shares be heading past the £2 barrier once more? More »

Why FTSE 100 growth stock NMC Health could trash the GSK share price

Roland Head | Monday, 22nd October, 2018

Roland Head compares the outlook for FTSE 100 (INDEXFTSE:UKX) healthcare stocks NMC Health plc (LON:NMC) and GlaxoSmithKline plc (LON:GSK). More »

Forget cash ISAs! Why bother when you can get 5.5% a year from investing in the GSK share price

Harvey Jones | Friday, 19th October, 2018

Harvey Jones says that FTSE 100 (INDEXFTSE: UKX) pharmaceutical giant GlaxoSmithKline plc (LON: GSK) pays around six times the income you will get from... More »

Is the GlaxoSmithKline share price a bargain or should I buy this high-yielding small-cap?

Kevin Godbold | Wednesday, 10th October, 2018

Does this small-cap share’s recovery potential outshine the forward prospects of GlaxoSmithKline plc (LON: GSK)? More »

GSK and Sopheon’s share prices have beaten the FTSE 100 by 20%, is it time to buy?

Peter Stephens | Monday, 8th October, 2018

Do GlaxoSmithKline plc (LON: GSK) and Sopheon plc (LON: SPE) offer further FTSE 100 (INDEXFTSE: UKX) outperformance potential? More »

Is this FTSE 250 faller set to bounce back and crush the GSK share price?

Alan Oscroft | Thursday, 4th October, 2018

The GlaxoSmithKline plc (LON: GSK) share price has climbed in 2018, but here's one that could beat it in 2019. More »